Dietary Caffeine Consumption and Withdrawal: Confounding Variables in Quantitative Cerebral Perfusion Studies?
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
PURPOSE: To evaluate the effects of dietary caffeine intake and withdrawal on cerebral blood flow (CBF), as determined from a randomized, blinded, placebo-controlled study. MATERIALS AND METHODS: Twenty adults (16 men, four women; age range, 24-64 years) categorized as low (mean, 41 mg/d) or high (mean, 648 mg/d) caffeine users underwent quantitative flow-sensitive alternating inversion-recovery perfusion magnetic resonance (MR) imaging twice: 90 minutes after a dose of caffeine (250 mg) on one day and after a dose of placebo on another day (randomized counterbalanced design). Doses were preceded by 30 hours of caffeine abstinence to induce withdrawal in high caffeine users. Quantitative CBF maps were gray matter (GM)-white matter (WM) segmented and subjected to region-of-interest analysis to obtain mean CBF in WM, anterior circulation GM (AGM), and posterior circulation GM (PGM). By using two-way repeated-measures analysis of variance, regional CBF data were tested for within-subject differences between caffeine and placebo and for between-subject differences related to dietary caffeine habits. Linear regression was used to determine whether dietary caffeine use predicts CBF or CBF response to caffeine. RESULTS: Caffeine reduced CBF (P < or =.05) by 23% (AGM, PGM) and 18% (WM) in all subjects. Postplacebo (withdrawal) CBF in high caffeine users exceeded that in low users (P < or =.05) by 31% (AGM) and 32% (WM) (PGM, not significant). Mean postcaffeine CBF reduction in AGM was 26% in high users versus 19% in low users (P < or =.05; PGM and WM, not significant). Increasing caffeine consumption predicted higher CBF (P < or =.05) in all regions: r = 0.79 (AGM), 0.57 (PGM), and 0.76 (WM). Dietary caffeine use did not predict CBF response to caffeine. CONCLUSION: Dietary caffeine consumption and withdrawal are potential confounding variables in cerebral perfusion and functional MR imaging.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a withdrawn state, habitual high consumers exhibit higher resting CBF as compared to low consumers, and caffeine use is significantly positively correlated with CBF following both placebo and caffeine (Addicott et al. 2009; Field et al. 2003).”
From A Double-Blind, Placebo-Controlled Study Evaluating the Effects of Caffeine and L-Theanine Both Alone and in Combination on Cerebral Blood Flow, Cognition and Mood (2015) · cites this paper as Field et al. 2003
In the citing paper
“In a withdrawn state, habitual high consumers exhibit higher resting CBF as compared to low consumers, and caffeine use is significantly positively correlated with CBF following both placebo and caffeine (Addicott et al. 2009; Field et al. 2003).”
From A Double-Blind, Placebo-Controlled Study Evaluating the Effects of Caffeine and L-Theanine Both Alone and in Combination on Cerebral Blood Flow, Cognition and Mood (2015) · cites this paper as Field et al. 2003
In the citing paper
“Effects of caffeine on CBF are also dependent upon the level of caffeine habitually consumed.”
From A Double-Blind, Placebo-Controlled Study Evaluating the Effects of Caffeine and L-Theanine Both Alone and in Combination on Cerebral Blood Flow, Cognition and Mood (2015) · cites this paper as Field et al. 2003
In the citing paper
“There is also evidence that, despite higher CBF overall, high consumers exhibit a greater acute reduction in CBF than low consumers in response to a 250 mg dose of caffeine administered whilst in a state of withdrawal (Field et al. 2003).”
From A Double-Blind, Placebo-Controlled Study Evaluating the Effects of Caffeine and L-Theanine Both Alone and in Combination on Cerebral Blood Flow, Cognition and Mood (2015) · cites this paper as Field et al. 2003
Citations
Cites
Oxygenation‐sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields
Ogawa, S., Lee, T., Nayak, A. S., & Glynn, P. (1990) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910140108 · Cited by 2,266
Functional cerebral imaging by susceptibility‐contrast NMR
Belliveau, J. W., Rosen, B. R., Kantor, H. L., Rzedzian, R. R., Kennedy, D. N., McKinstry, R. C., Vevea, J. M., Cohen, M. S., Pykett, I. L., & Brady, T. J. (1990) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910140311 · Cited by 570
Are we dependent upon coffee and caffeine? A review on human and animal data
Nehlig, A. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00050-5 · Cited by 453
Edvinsson, L., Owman, C., & Sjo¨berg, N.-O. (1976) · Brain Research · doi:10.1016/0006-8993(76)90356-5 · Cited by 443
Caffeine content of common beverages
BUNKER, M. L., & McWILLIAMS, M. (1979) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)39775-9 · Cited by 303
Caffeine physical dependence: a review of human and laboratory animal studies
Griffiths, R. R., & Woodson, P. P. (1988) · Psychopharmacology · doi:10.1007/bf00212836 · Cited by 276
Svenningsson, P., Hall, H., Sedvall, G., & Fredholm, B. B. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199712)27:4<322::aid-syn6>3.0.co;2-e · Cited by 230
Arnaud, M. J. (1987) · Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrès des recherches pharmaceutiques · doi:10.1007/978-3-0348-9289-6_9 · Cited by 219 · cited 1×
“5 hours [14]).”
Low-dose caffeine physical dependence in humans.
Griffiths, R. R., Evans, S. M., Heishman, S. J., Preston, K. L., Sannerud, C. A., Wolf, B., & Woodson, P. P. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23150-0 · Cited by 182
Ince, E., Ciliax, B. J., & Levey, A. I. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199712)27:4<357::aid-syn9>3.0.co;2-b · Cited by 175
Caffeine and human cerebral blood flow: A positron emission tomography study
Cameron, O. G., Modell, J. G., & Hariharan, M. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90174-p · Cited by 170
On the Use of Caffeine as a Contrast Booster for BOLD fMRI Studies
Mulderink, T. A., Gitelman, D. R., Mesulam, M.-M., & Parrish, T. B. (2002) · NeuroImage · doi:10.1006/nimg.2001.0973 · Cited by 164
Adenosine in the control of the cerebral circulation.
Phillis, J. W. (1989) · PubMed · Cited by 163
Multislice imaging of quantitative cerebral perfusion with pulsed arterial spin labeling
Yang, Y., Frank, J. A., Hou, L., Ye, F. Q., McLaughlin, A. C., & Duyn, J. H. (1998) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910390520 · Cited by 155
Dietary Caffeine Consumption Modulates fMRI Measures
Laurienti, P. J., Field, A. S., Burdette, J. H., Maldjian, J. A., Yen, Y.-F., & Moody, D. M. (2002) · NeuroImage · doi:10.1006/nimg.2002.1237 · Cited by 136
Self-citationJennings, L. L., Hao, C., Cabrita, M. A., Vickers, M. F., Baldwin, S. A., Young, J. D., & Cass, C. E. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00207-0 · Cited by 124
A1 and A2A adenosine receptors and A1 mRNA in mouse brain: effect of long-term caffeine treatment
Johansson, B., Georgiev, V., Lindström, K., & Fredholm, B. B. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00378-8 · Cited by 104
The effects of caffeine on various body systems: A review
Leonard, T. K., Watson, R. R., & Mohs, M. E. (1987) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)03240-5 · Cited by 90
Yen, Y., Field, A. S., Martin, E. M., Ari, N., Burdette, J. H., Moody, D. M., & Takahashi, A. (2002) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10140 · Cited by 86
Self-citation(2003) · PubMed Central · Cited by 75
Self-citationInfluence of Caffeine and Caffeine Withdrawal on Headache and Cerebral Blood Flow Velocities
Couturier, E., Laman, D., van Duijn, M., & van Duijn, H. (1997) · Cephalalgia · doi:10.1046/j.1468-2982.1997.1703188.x · Cited by 74
Effects of Various Drugs Upon Cerebral Circulation and Metabolism of Man
Shenkin, H. A. (1951) · Journal of Applied Physiology · doi:10.1152/jappl.1951.3.8.465 · Cited by 74
Caffeine and Cerebral Blood Flow
Mathew, R. J., Barr, D. L., & Weinman, M. L. (1983) · British Journal of Psychiatry · doi:10.1192/bjp.143.6.604 · Cited by 67
Jones, H. E., Herning, R. I., Cadet, J. L., & Griffiths, R. R. (2000) · Psychopharmacology · doi:10.1007/s002130050005 · Cited by 64
Caffeine Consumption, Withdrawal and Cerebral Blood Flow
Mathew, R. J., & Wilson, W. H. (1985) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1985.hed2506305.x · Cited by 55
Brain imaging and the effects of caffeine and nicotine
Dager, S. R., & Friedman, S. D. (2000) · Annals of Medicine · doi:10.3109/07853890009002029 · Cited by 54
Adenosine A1-receptors in human brain: Characterization and autoradiographic visualization
Fastbom, J., Pazos, Á., Probst, A., & Palacios, J. M. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90291-0 · Cited by 49
The cerebral blood flow in man as influenced by adrenalin, caffein, amyl nitrite and histamine
Gibbs, F. A., Gibbs, E. L., & Lennox, W. G. (1935) · American Heart Journal · doi:10.1016/s0002-8703(35)90421-5 · Cited by 38
Caffeine reduces dipyridamole-induced myocardial ischemia.
Smits, P., Aengevaeren, W. R. M., Corstens, F. H. M., & Thien, T. (1989) · PubMed · Cited by 34
Traversa, U., Am, R., Florio, C., & Vertua, R. (1994) · PubMed · Cited by 14
Caffeine as a BOLD contrast booster
Parrish, T. B., Mulderink, T. A., Gitelman, D. R., & Mesulam, M. M. (2001) · NeuroImage · doi:10.1016/s1053-8119(01)92338-9 · Cited by 6
Research works printed but not linked: 1
- Laurienti PJ, Field AS, Burdette JH, Maldjian JA, Yen YF, Moody DM.The relationship between caffeine-induced changes in resting cerebral perfusion and BOLD signal.AJNR Amer J Neuroradiol. (in press).
Cited by
Juliano, L. M., & Griffiths, R. R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2000-x · Cited by 581
“The magnitude of this effect is positively correlated with daily caffeine dose before abstinence (Mathew and Wilson 1985; Field et al. 2003).”
Uludağ, K., Dubowitz, D. J., Yoder, E. J., Restom, K., Liu, T. T., & Buxton, R. B. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.05.013 · Cited by 249
“The feed-forward model of neurovascular coupling can be used to investigate the mechanisms of action of other exogenous agents that alter CBF, such as caffeine or alcohol (or a mix of both) (Field et al., 2003; Mulderink et al., 2002; Schmalbruch et al., 2002; Seifritz et al., 2000).”
BackgroundCaffeine and cardiovascular health
Turnbull, D., Rodricks, J. V., Mariano, G. F., & Chowdhury, F. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.07.025 · Cited by 216
The effect of daily caffeine use on cerebral blood flow: How much caffeine can we tolerate?
Addicott, M. A., Yang, L. L., Peiffer, A. M., Burnett, L. R., Burdette, J. H., Chen, M. Y., Hayasaka, S., Kraft, R. A., Maldjian, J. A., & Laurienti, P. J. (2009) · Human Brain Mapping · doi:10.1002/hbm.20732 · Cited by 210
“A 250 mg dose of caffeine has been shown to reduce resting cerebral blood flow (CBF) between 22 and 30% (Cameron et al., 1990; Field et al., 2003; Lunt et al., 2004).”
BackgroundInfluentialSelf-citationArterial Spin-Labeling in Routine Clinical Practice, Part 3: Hyperperfusion Patterns
Deibler, A. R., Pollock, J. M., Kraft, R. A., Tan, H., Burdette, J. H., & Maldjian, J. A. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1034 · Cited by 193
Self-citation
Metadata
- Authors
- Field, A. S., Laurienti, P. J., Yen, Y.-F., Burdette, J. H., & Moody, D. M.
- Affiliations
- Wake Forest University Health Sciences (US)
- University of Wisconsin–Madison (US)
- Venue
- Radiology
- Published
- 2003-04
- Volume
- 227
- Issue
- 1
- Pages
- 129-135
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2116721966
- Cited by
- 115
- References
- 30
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 5 · 2017: 9 · 2016: 6 · 2015: 5 · 2014: 6 · 2013: 4 · 2012: 7
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Radiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Keywords
- dietary caffeine, caffeine withdrawal, cerebral blood flow, confounding variables, gray matter, white matter, functional MRI
- MeSH terms
- Caffeine, Cerebrovascular Circulation, Humans, Regression Analysis, Confounding Factors, Epidemiologic, Single-Blind Method
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.